Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Poole

Showing results (61-70 of 1,034) with videos related to

Pageof 104
Sort By:
Cardiology Clinics|March 4, 2008
Differences in European and North American approaches to the management of heart failurePhilip A Poole-Wilson
Timely Topics in Medicine. Cardiovascular Diseases|February 26, 2008
Chronic heart failurePhilip A Poole-Wilson
European Heart Journal|August 1, 1996
The calcium antagonist controversy; implications beyond drug prescriptionP A Poole-Wilson
Postgraduate Medical Journal|January 1, 1991
Calcium channels in the heartP A Poole-Wilson
Clinical Physiology (Oxford, England)|December 1, 1987
Reperfusion damage in heart muscle: still unexplained but with new clinical relevanceP A Poole-Wilson
European Heart Journal|June 1, 1989
Relevance of the aetiology of heart failure to drug therapyP A Poole-Wilson
Journal of Molecular and Cellular Cardiology|June 1, 1978
Measurement of myocardial intracellular pH in pathological statesP A Poole-Wilson
Lancet (London, England)|July 15, 1989
Thrombolytic therapyP A Poole-Wilson
Clinical Science and Molecular Medicine|August 1, 1976
The kinetics of efflux of 5,5-dimethyl-2,4-oxazolidinedione (DMO) from the myocardiumP A Poole-Wilson
Drugs|January 1, 1986
The future role of inotropic drugsP A Poole-Wilson
Pageof 104

Showing results (61-70 of 1,034) with videos related to

Sort By:
Pageof 104
Cardiology Clinics|March 4, 2008
Differences in European and North American approaches to the management of heart failurePhilip A Poole-Wilson
Timely Topics in Medicine. Cardiovascular Diseases|February 26, 2008
Chronic heart failurePhilip A Poole-Wilson
European Heart Journal|August 1, 1996
The calcium antagonist controversy; implications beyond drug prescriptionP A Poole-Wilson
Postgraduate Medical Journal|January 1, 1991
Calcium channels in the heartP A Poole-Wilson
Clinical Physiology (Oxford, England)|December 1, 1987
Reperfusion damage in heart muscle: still unexplained but with new clinical relevanceP A Poole-Wilson
European Heart Journal|June 1, 1989
Relevance of the aetiology of heart failure to drug therapyP A Poole-Wilson
Journal of Molecular and Cellular Cardiology|June 1, 1978
Measurement of myocardial intracellular pH in pathological statesP A Poole-Wilson
Lancet (London, England)|July 15, 1989
Thrombolytic therapyP A Poole-Wilson
Clinical Science and Molecular Medicine|August 1, 1976
The kinetics of efflux of 5,5-dimethyl-2,4-oxazolidinedione (DMO) from the myocardiumP A Poole-Wilson
Drugs|January 1, 1986
The future role of inotropic drugsP A Poole-Wilson
Pageof 104